Role of monoamine oxidase inhibition in formation of hypersensitivity of delayed type

1969 ◽  
Vol 67 (1) ◽  
pp. 56-58
Author(s):  
L. V. Devoino ◽  
L. S. Korovina ◽  
V. A. Maslakova
Keyword(s):  
Monoamine Oxidase ◽  
Monoamine Oxidase Inhibition ◽  
Hypersensitivity Of Delayed Type ◽  
Oxidase Inhibition

Role of Monoamine Oxidase Inhibition and Monoamine Depletion in Fenfluramine-Induced Neurotoxicity and Serotonin Release

2001 ◽  
Vol 89 (5) ◽  
pp. 237-248 ◽  
Author(s):  
Alycia K. Halladay ◽  
Emily Kirschner ◽  
Kelly Hesse ◽  
Hans Fisher ◽  
George C. Wagner
Keyword(s):  
Monoamine Oxidase ◽  
Serotonin Release ◽  
Monoamine Oxidase Inhibition ◽  
Oxidase Inhibition ◽  
Monoamine Depletion

scholarly journals Role of Monoamine Oxidase Inhibition and Monoamine Depletion in Fenfluramine-Induced Neurotoxicity and Serotonin Release

2008 ◽  
Vol 89 (5) ◽  
pp. 237-248
Author(s):  
Alycia K. Halladay ◽  
Emily Kirschner ◽  
Kelly Hesse ◽  
Hans Fisher ◽  
George C. Wagner
Keyword(s):  
Monoamine Oxidase ◽  
Serotonin Release ◽  
Monoamine Oxidase Inhibition ◽  
Oxidase Inhibition ◽  
Monoamine Depletion

Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline

1989 ◽  
Vol 46 (5) ◽  
pp. 528-536 ◽  
Author(s):  
Rainer Schulz ◽  
Karl-Heinz Antonin ◽  
Edgar Hoffmann ◽  
Maria Jedrychowski ◽  
Eric Nilsson ◽  
...  
Keyword(s):  
Monoamine Oxidase ◽  
Monoamine Oxidase Inhibition ◽  
Oxidase Inhibition

scholarly journals Glycaemic control by monoamine oxidase inhibition in a patient with type 1 diabetes

2016 ◽  
Vol 14 (2) ◽  
pp. 163-165 ◽  
Author(s):  
Hamlin Emory ◽  
Neptune Mizrahi
Keyword(s):  
Type 1 Diabetes ◽  
Glycaemic Control ◽  
Monoamine Oxidase ◽  
Monoamine Oxidase Inhibitor ◽  
Combined Treatment ◽  
Insulin Regimen ◽  
Imaging Data ◽  
Monoamine Oxidase Inhibition ◽  
Oxidase Inhibition

We present clinical, electroencephalographic and low-resolution electromagnetic tomography data that support combined treatment with insulin and a monoamine oxidase inhibitor in a patient with type 1 diabetes. We suggest that brain imaging data can identify a subgroup of patients who are likely to benefit from an insulin regimen and monoamine oxidase inhibition to improve glycaemic control, cardiovascular function, normalize the circadian rhythm and restore perception of glycaemic awareness.

N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells

2017 ◽  
Vol 42 (11) ◽  
pp. 3289-3295 ◽  
Author(s):  
David S. Goldstein ◽  
Yunden Jinsmaa ◽  
Patti Sullivan ◽  
Yehonatan Sharabi
Keyword(s):  
Monoamine Oxidase ◽  
Pc12 Cells ◽  
Monoamine Oxidase Inhibition ◽  
Oxidase Inhibition ◽  
Spontaneous Oxidation
Sign in / Sign up

Export Citation Format

Share Document